Learn more

AICHI MEDICAL UNIV

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    83,444
  • Filing trend
    ⇧ 166.0%
About

AICHI MEDICAL UNIV has a total of 27 patent applications. It increased the IP activity by 166.0%. Its first patent ever was published in 2011. It filed its patents most often in Japan, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are BIOVAXIM LTD, BIOSANTE PHARMACEUTICALS INC and Smart surgical inc.

Patent filings in countries

World map showing AICHI MEDICAL UNIVs patent filings in countries
# Country Total Patents
#1 Japan 18
#2 EPO (European Patent Office) 3
#3 China 2
#4 WIPO (World Intellectual Property Organization) 2
#5 Brazil 1
#6 United States 1

Patent filings per year

Chart showing AICHI MEDICAL UNIVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Naito Munekazu 7
#2 Hatayama Naoyuki 7
#3 Sakaue Shigeki 6
#4 Hirai Shuichi 4
#5 Sugiura Nobuo 4
#6 Hirai Soichi 3
#7 Fukushige Kaori 3
#8 Umezawa Kazuo 3
#9 Yamauchi Masato 2
#10 Takeuchi Kosei 2

Latest patents

Publication Filing date Title
WO2019230973A1 Composition for preserving biomaterial, method for preserving biomaterial, method for producing biomaterial, transplantation material and transplantation method
CN112218940A Composition, cell preservation composition, cell culture composition, cell preparation, method for producing object containing microbubbles, method for preserving cells, method for culturing cells, and method for producing cell preparation
JP2020143036A Liposome, and antimalaria agent containing the same
JP2020089280A Composition, sweetness imparting composition, flavor improving composition, method for producing object containing fine foam, sweetness imparting method, flavor improving method, food and drink, and method for producing food and drink
JP2020005979A Ophthalmic surgical instrument
JP2018201499A Mesenchymal stem cell having improved safety and anti-inflammatory action
JP2019187949A Intraocular lens fixation instrument
JP2019172580A Hyaluronic acid synthesis inhibitor, and agent for treating or preventing disease or condition associated with hyaluronic acid
JP2019158687A Detection and preparation of effector control t-cell
US2021102214A1 Antisense nucleic acid for inhibiting biosynthesis of chondroitin
JP2019064973A No production inhibitor and metastasis/invasion inhibitor for solid tumor
JP2018035149A Cord blood hematopoietic stem cell support
JP2018141636A Dose Evaluation Device, Dose Measuring Device, Irradiation Time Evaluation Device, Dose Evaluation Method and Dose Evaluation Program
JP2016113419A Fatty liver and steatohepatitis therapeutic agent
JP2016015942A Method for determining sequence structure of glycosaminoglycan sugar chain
JP2014079420A Blood vessel pressing device used in embolo/sclerotherapy for vascular malformation
JP2012175969A Enzyme for degrading chondroitin or chondroitin sulfate, reagent, degrading method, method for producing highly sulfated oligosaccharide and composition
JP2011217736A Recombinant chlamydia and method for producing the same
JP2012035052A Informing device
JP2011194224A Tomographic image processing device, and tomographic image processing method